These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

405 related items for PubMed ID: 18615681

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Imatinib induces a cytogenetic response in blast crisis or interferon failure chronic myeloid leukemia patients with e19a2 BCR-ABL transcripts.
    Lee JJ, Kim HJ, Kim YJ, Lee S, Hwang JY, Kim YL, Kim DW.
    Leukemia; 2004 Sep; 18(9):1539-40. PubMed ID: 15284852
    [No Abstract] [Full Text] [Related]

  • 3. Clinical and genetic studies of ETV6/ABL1-positive chronic myeloid leukaemia in blast crisis treated with imatinib mesylate.
    Barbouti A, Ahlgren T, Johansson B, Höglund M, Lassen C, Turesson I, Mitelman F, Fioretos T.
    Br J Haematol; 2003 Jul; 122(1):85-93. PubMed ID: 12823349
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Hematological and molecular response evaluation of CML patients on imatinib.
    Gupta A, Prasad K.
    J Assoc Physicians India; 2007 Feb; 55():109-13. PubMed ID: 17571739
    [Abstract] [Full Text] [Related]

  • 6. e6a2 BCR/ABL1 fusion with cryptic der(9)t(9;22) deletions in a patient with chronic myeloid leukemia.
    Roti G, La Starza R, Gorello P, Gottardi E, Crescenzi B, Martelli MF, Mecucci C.
    Haematologica; 2005 Aug; 90(8):1139-41. PubMed ID: 16079118
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Complete response to imatinib mesylate treatment in a 12-month-old patient with chronic myeloid leukemia.
    Arancibia AM, Bendit I, Epelman S.
    Pediatr Blood Cancer; 2008 May; 50(5):1078. PubMed ID: 18085674
    [No Abstract] [Full Text] [Related]

  • 10. Isolated central nervous system relapse after nine years of complete molecular remission in a lymphoid blast crisis of chronic myeloid leukemia treated with imatinib.
    Breccia M, Santopietro M, Cannella L, Federico V, Loglisci G, Serrao A, Petrucci L, Salaroli A, Nanni M, De Propris MS, Diverio D, Alimena G.
    Leuk Res; 2011 Jun; 35(6):e91-2. PubMed ID: 21316103
    [No Abstract] [Full Text] [Related]

  • 11. Imatinib mesylate therapy in chronic myeloid leukaemia: the floodgates opened.
    Agarwal MB.
    J Assoc Physicians India; 2007 Feb; 55():99-100. PubMed ID: 17571737
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Detection of BCR-ABL gene mutations in Philadelphia chromosome positive leukemia patients resistant to STI-571 cancer therapy.
    Chien JH, Tang JL, Chen RL, Li CC, Lee CP.
    Leuk Res; 2008 Nov; 32(11):1724-34. PubMed ID: 18603297
    [Abstract] [Full Text] [Related]

  • 14. New-age drug meets resistance.
    McCormick F.
    Nature; 2001 Jul 19; 412(6844):281-2. PubMed ID: 11460142
    [No Abstract] [Full Text] [Related]

  • 15. Imatinib and chronic-phase leukemias.
    Boros LG, Lee WN, Cascante M.
    N Engl J Med; 2002 Jul 04; 347(1):67-8. PubMed ID: 12097546
    [No Abstract] [Full Text] [Related]

  • 16. Biclonal blast crisis with a mutated ABL catalytic domain in a Ph, del (9q)-positive CML patient responsive to imatinib: drug resistance should be monitored in all patients irrespective of response status.
    Alimena G, Breccia M, Mancini M, Diverio D, Nanni M, De Propris MS, Cimino G, Pane F, Mandelli F.
    Leukemia; 2005 Feb 04; 19(2):287-9. PubMed ID: 15538403
    [No Abstract] [Full Text] [Related]

  • 17. Coexistence of different clonal populations harboring the b3a2 (p210) and e1a2 (p190) BCR-ABL1 fusion transcripts in chronic myelogenous leukemia resistant to imatinib.
    Agirre X, Román-Gómez J, Vázquez I, Jiménez-Velasco A, Larráyoz MJ, Lahortiga I, Andreu EJ, Márquez J, Beltrán de Heredia JM, Odero MD, Prósper F, Calasanz MJ.
    Cancer Genet Cytogenet; 2005 Jul 01; 160(1):22-6. PubMed ID: 15949566
    [Abstract] [Full Text] [Related]

  • 18. Promyelocytic blast crisis of chronic myeloid leukemia during imatinib treatment.
    Chung HJ, Chi HS, Cho YU, Park CJ, Seo EJ, Kim KH, Lee JH.
    Ann Clin Lab Sci; 2008 Jul 01; 38(3):283-6. PubMed ID: 18715859
    [Abstract] [Full Text] [Related]

  • 19. Emerging kinetics of BCR-ABL1 mutations and their effect on disease outcomes in chronic myeloid leukemia patients with imatinib failure.
    Shih LY, Kuo MC, Kuo CY, Lin TH, Bai LY, Chen TY, Wang MC, Lin TL, Lan YJ, Chen CC, Yang Y, Hsiao PC, Lai CL, Chang CH, Lin TH.
    Leuk Res; 2013 Jan 01; 37(1):43-9. PubMed ID: 23062378
    [Abstract] [Full Text] [Related]

  • 20. Chronic myeloid leukemia with an e13a3 BCR-ABL fusion: benign course responsive to imatinib with an RT-PCR advisory.
    Snyder DS, McMahon R, Cohen SR, Slovak ML.
    Am J Hematol; 2004 Feb 01; 75(2):92-5. PubMed ID: 14755375
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.